• Study of Telitacicept for Treating Generalized Myasthenia Gravis in Patients

    Recruiting

    3 1
    Investigated drugs:
    Belgium Bulgaria Czechia Denmark France Italy +2
  • Study on Evolocumab for Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Poland Spain
  • Study of Namodenoson Treatment in Patients with Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis

    Recruiting

    2 1
    Investigated drugs:
    Bulgaria Poland Romania
  • Study on the Effects of Filgotinib for Children and Teenagers with Moderate to Severe Ulcerative Colitis

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Croatia France Germany Greece Ireland +6
  • Study of Vedolizumab for Children with Moderate to Severe Ulcerative Colitis or Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria Denmark Ireland Italy The Netherlands +4
  • Study on Valsartan for Slowing Aortic Root Dilatation in Children and Young Adults with Marfan Syndrome and Related Conditions

    Recruiting

    3 1 1
    Investigated drugs:
    Poland
  • Study on Azithromycin for Treating Hospitalized Children Aged 1-5 with Asthma Symptoms

    Recruiting

    2 1 1
    Investigated diseases:
    Denmark
  • Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn’s Disease

    Recruiting

    2 1 1
    Austria Belgium Bulgaria Croatia Czechia Denmark +17
  • A Phase 2 Study of Methylenedioxymethamphetamine‑Assisted Therapy in Young Adults (18‑25) with Chronic Treatment‑Resistant Major Depressive Disorder

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Norway
  • Effect of dry extract from Psilocybe cubensis (15‑25:1), extraction solvent methanol, with psychotherapy versus basic support on depressive symptoms in adults with depression

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Denmark

powered by